Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
Behavioral effects of Bj-PRO-7a, a proline-rich oligopeptide from Bothrops jararaca venom
|
Autores: |
Turones,L.C.
Cruz,K.R. da
Camargo-Silva,G.
Reis-Silva,L.L.
Graziani,D.
Ferreira,P.M.
Galdino,P.M.
Pedrino,G.R.
Santos,R.
Costa,E.A.
Ianzer,D.
Xavier,C.H.
|
Data: |
2019-01-01
|
Ano: |
2019
|
Palavras-chave: |
Bj-PRO-7a
Snake venom
Neuroactive compounds
Anxiety
Depression
Behavior
|
Resumo: |
The heptapeptide Bj-PRO-7a, isolated and identified from Bothrops jararaca (Bj) venom, produces antihypertensive and other cardiovascular effects that are independent on angiotensin converting enzyme inhibition, possibly relying on cholinergic muscarinic receptors subtype 1 (M1R). However, whether Bj-PRO-7a acts upon the central nervous system and modifies behavior is yet to be determined. Therefore, the aims of this study were: i) to assess the effects of acute administration of Bj-PRO-7a upon behavior; ii) to reveal mechanisms involved in the effects of Bj-PRO-7a upon locomotion/exploration, anxiety, and depression-like behaviors. For this purpose, adult male Wistar (WT, wild type) and spontaneous hypertensive rats (SHR) received intraperitoneal injections of vehicle (0.9% NaCl), diazepam (2 mg/kg), imipramine (15 mg/kg), Bj-PRO-7a (71, 213 or 426 nmol/kg), pirenzepine (852 nmol/kg), α-methyl-DL-tyrosine (200 mg/kg), or chlorpromazine (2 mg/kg), and underwent elevated plus maze, open field, and forced swimming tests. The heptapeptide promoted anxiolytic and antidepressant-like effects and increased locomotion/exploration. These effects of Bj-PRO-7a seem to be dependent on M1R activation and dopaminergic receptors and rely on catecholaminergic pathways.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019001100606
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/1414-431x20198441
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.52 n.11 2019
|
Direitos: |
info:eu-repo/semantics/openAccess
|
|